China's Jiuyuan Genetic seeks approval for Wegovy biosimilar [Yahoo! Finance]
JD.com, Inc. - American Depositary Shares (JD)
Last jd.com, inc. - american depositary shares earnings: 3/2 05:03 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.jd.com
Company Research
Source: Yahoo! Finance
blockbuster weight-loss drug Wegovy in China, ?the Chinese drugmaker said Wednesday. The move comes ahead of a key patent ?expiry in the world's second largest pharmaceutical market. In a filing, Jiuyuan, based in the eastern city of Hangzhou, told the Hong Kong stock exchange it was seeking approval to sell Jikeqin ?for weight management ?to the obese or overweight. Biosimilars are close copies of biological drugs. Jiuyuan said results of a Phase ?III trial in subjects with obesity showed Jikeqin was "clinically equivalent" to a reference drug in terms of its safety profile, and ?in ?the percent change in patient ?body weight from baseline after ?44 weeks after treatment. The trial enrolled 370 patients, Jiuyuan said in its 2024 annual report. A spokesperson for Jiuyuan told Reuters the comparator drug was Wegovy. Jiuyuan is among drugmakers in China developing biosimilar versions of Wegovy or a Novo ?diabetes drug, Ozempic, ahead of the ?March expiry of the patent on ?th
Show less
Read more
Impact Snapshot
Event Time:
JD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JD alerts
High impacting JD.com, Inc. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
JD
News
- A Look At JD.com (JD) Valuation As JoyExpress Expands Its European Logistics Network [Yahoo! Finance]Yahoo! Finance
- Is JD.com's Europe-Wide JoyExpress Rollout Reshaping The Investment Case For JD (JD)? [Yahoo! Finance]Yahoo! Finance
- Victory Diversified Stock Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- JD.com to Report Fourth Quarter and Full Year 2025 Financial Results on March 5, 2026 [Yahoo! Finance]Yahoo! Finance
- JD.com to Report Fourth Quarter and Full Year 2025 Financial Results on March 5, 2026GlobeNewswire
JD
Earnings
- 11/13/25 - Beat
JD
Sec Filings
- 2/20/26 - Form 6-K
- 1/21/26 - Form SCHEDULE
- 1/8/26 - Form 6-K
- JD's page on the SEC website